EGF and urogenital neoplasm: For instance, changes in circulating levels of epidermal growth factor (EGF) and transforming growth factor beta 1 (TGFβ1), due to functional genetic variants, could influence the risk to develop prostate and lung cancer, respectively (Teixeira et al., 2008, 2011).